Another coronavirus vaccine trial shows promise
Neal Browning receives a shot in the first-stage safety study of a potential vaccine for COVID-19 at the Kaiser Permanente Washington Health Research Institute in Seattle. Moderna said Monday, Nov. 16, its coronavirus vaccine is proving to be highly effective in a major trial.
In the last week or so, there has been some good vaccine news. Pfizer and now Moderna have announced that their coronavirus vaccines were 90% and 94.5% effective based on preliminary results from their trials. And, as the US finds itself at a crossroads between one president and another, the United Nations happens to be conducting its regular review of where the US stands on human rights, as it does every four years with each of its member states. Also, one of the most important telescopes in the world, the Arecibo Observatory in Puerto Rico, is on the brink of collapse after two supporting cables snapped.
Big news! The World is participating in NewsMatch. From now until the end of the year, every dollar of support will be generously matched by a coalition of national funders. This means a gift of $50 will provide $100 of support for The World’s critical journalism. Double your impact today!
Thank you for your support. Visit www.theworld.org/give to donate.
